- Home
- CLDI vs FEDU Comparison
CLDI vs FEDU Comparison
Compare CLDI & FEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- FEDU
- Stock Information
- Founded
- CLDI 2014
- FEDU 2007
- Country
- CLDI United States
- FEDU China
- Employees
- CLDI N/A
- FEDU N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- FEDU
- Sector
- CLDI Health Care
- FEDU
- Exchange
- CLDI Nasdaq
- FEDU NYSE
- Market Cap
- CLDI 10.2M
- FEDU 21.6M
- IPO Year
- CLDI N/A
- FEDU 2017
- Fundamental
- Price
- CLDI $0.71
- FEDU $14.60
- Analyst Decision
- CLDI
- FEDU
- Analyst Count
- CLDI 0
- FEDU 0
- Target Price
- CLDI N/A
- FEDU N/A
- AVG Volume (30 Days)
- CLDI 41.3M
- FEDU 1.8K
- Earning Date
- CLDI 08-12-2025
- FEDU 07-22-2025
- Dividend Yield
- CLDI N/A
- FEDU 14.25%
- EPS Growth
- CLDI N/A
- FEDU N/A
- EPS
- CLDI N/A
- FEDU 0.05
- Revenue
- CLDI N/A
- FEDU $34,475,202.00
- Revenue This Year
- CLDI N/A
- FEDU N/A
- Revenue Next Year
- CLDI N/A
- FEDU N/A
- P/E Ratio
- CLDI N/A
- FEDU $328.78
- Revenue Growth
- CLDI N/A
- FEDU 100.15
- 52 Week Low
- CLDI $0.20
- FEDU $3.69
- 52 Week High
- CLDI $3.89
- FEDU $22.70
- Technical
- Relative Strength Index (RSI)
- CLDI 65.65
- FEDU 84.66
- Support Level
- CLDI $0.23
- FEDU $10.71
- Resistance Level
- CLDI $1.60
- FEDU $12.00
- Average True Range (ATR)
- CLDI 0.15
- FEDU 0.41
- MACD
- CLDI 0.07
- FEDU 0.27
- Stochastic Oscillator
- CLDI 36.55
- FEDU 100.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)
Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.